조현병 장애 등급 평가와 한국판 University of California San Diego 실행에 기초한 기술평가 척도의 유용성
Assessment of the Disability Grade of Schizophrenia and the Usefulness of the Korean Version of the University of California San Diego Performance-Based Skills Assessment
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives：The purpose of this study was to supplement the evaluation criteria for the schizophrenia disability grading system through a standardized test. Methods：Patients with schizophrenia were divided into three groups according to their Global Assessment Function(GAF) scores, which correspond to the disability grade of schizophrenia. We evaluated and compared the functional outcomes of patients with schizophrenia belonging to different severity groups. We performed the UCSD Performance-Based Skills Assessment(UPSA) and GAF to assess functioning in daily life, and the Positive and Negative Syndrome Scale(PANSS) and Clinical Global Impression-Schizophrenia Scale(CGI-SCH) to assess clinical symptoms. One-way analysis of variance was used for comparison between the three groups. The correlation between UPSA and other scale scores was analyzed by Pearson’s correlation coefficient. Results：A total of 117 patients were enrolled in this study. Of these, 46 were mild, 38 were moderate, and 33 were severe group. Significant differences in UPSA scores were identified between groups. The UPSA score was 71.54±14.12, 60.66±17.97, and 48.65±18.55 points for the mild, moderate, and severe group, respectively(p<0.001). The PANSS score was 53.83±15.67, 69.48±12.52, and 95.33±17.17 points for the mild, moderate, and severe group, respectively(p<0.001). The CGI-SCH score was 2.57±0.89, 3.08±0.94, and 4.18±1.01 points for the mild, moderate, and severe group, respectively(p<0.001). In addition, GAF, PANSS, and CGI-SCH showed a significant correlation with UPSA(correlation coefficient: 0.557, -0.497, and -0.570, respectively). Conclusion：The UPSA is a useful tool for assessing functions of daily living in patients with schizophrenia, and can be used to systematically measure the functional ability of patients according to their disability grade.
Abstract
Objectives：The purpose of this study was to supplement the evaluation criteria for the schizophrenia disability grading system through a standardized test. Methods：Patients with schizophrenia were divided into three groups according to their Global Assessment Function(GAF) scores, which correspond to the disability grade of schizophrenia. We evaluated and compared the functional outcomes of patients with schizophrenia belonging to different severity groups. We performed the UCSD Performance-Based Skills Assessment(UPSA) and GAF to assess functioning in daily life, and the Positive and Negative Syndrome Scale(PANSS) and Clinical Global Impression-Schizophrenia Scale(CGI-SCH) to assess clinical symptoms. One-way analysis of variance was used for comparison between the three groups. The correlation between UPSA and other scale scores was analyzed by Pearson’s correlation coefficient. Results：A total of 117 patients were enrolled in this study. Of these, 46 were mild, 38 were moderate, and 33 were severe group. Significant differences in UPSA scores were identified between groups. The UPSA score was 71.54±14.12, 60.66±17.97, and 48.65±18.55 points for the mild, moderate, and severe group, respectively(p<0.001). The PANSS score was 53.83±15.67, 69.48±12.52, and 95.33±17.17 points for the mild, moderate, and severe group, respectively(p<0.001). The CGI-SCH score was 2.57±0.89, 3.08±0.94, and 4.18±1.01 points for the mild, moderate, and severe group, respectively(p<0.001). In addition, GAF, PANSS, and CGI-SCH showed a significant correlation with UPSA(correlation coefficient: 0.557, -0.497, and -0.570, respectively). Conclusion：The UPSA is a useful tool for assessing functions of daily living in patients with schizophrenia, and can be used to systematically measure the functional ability of patients according to their disability grade.
참고문헌 (24)
- Heinrichs RW, "Neurocognitive deficit in schizophrenia: a quantitative review of the evidence", Neuropsychology, 12, pp.426~445 (1998)[DOI]
- Weinberger DR, "Cognitive function in schizophrenia", Int Clin Psychopharmacol, 12(Suppl 4), pp.S29~S36 (1997)
- Green MF, "Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS", Schizophr Res, 72, pp.41~51 (2004)[DOI]
- Wiersma D, "Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres", Psychol Med, 30, pp.1155~1167 (2000)[DOI]
- Ucok A, "Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study", Eur Psychiatry, 27, pp.422~425 (2012)[DOI]
- Cloutier M, "The Economic Burden of Schizophrenia in the United States in 2013", J Clin Psychiatry, 77, pp.764~771 (2016)
- 장성만, "Economic Burden of Schizophrenia in South Korea", Journal of Korean Medical Science, 23(2), pp.167~175 (2008), 대한의학회
- Ho BC, "Dependence on public financial support early in the course of schizophrenia", Psychiatr Serv, 48, pp.948~950 (1997)[DOI]
- 2014년 장애인 실태조사, "김성희", 한국보건사회연구원, ~ (2014)
- Son MJ, "A Study on the Development of Functional Assessment Scale for persons with psychiatric disability", Kor J Clin Psychol, 20, pp.731~749 (2001)
- Patterson TL, "UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults", Schizophr Bull, 27, pp.235~245 (2001)[DOI]
- Guze SB, "Diagnostic and statistical manual of mental disorders(DSM-IV)", Am J Psychiatry, 152, pp.1228~ (1995)[DOI]
- Rey MJ, "Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics", Int Clin Psychopharmacol, 4, pp.95~104 (1989)[DOI]
- Sung Jin Kim, "The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity", Clinical Psychopharmacology and Neuroscience, 15(3), pp.261~268 (2017), 대한정신약물학회[DOI]
- Kay SR, "The positive and negative syndrome scale(PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)[DOI]
- 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
- Hall RC, "Global assessment of functioning. A modified scale", Psychosomatics, 36, pp.267~275 (1995)[DOI]
- Haro JM, "The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia", Acta Psychiatr Scand, (Suppl), pp.16~23 (2003)
- Piersma HL, "The GAF and psychiatric outcome: a descriptive report", Community Ment Health J, 33, pp.35~41 (1997)[DOI]
- Wykes T, "A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes", Am J Psychiatry, 168, pp.472~485 (2011)[DOI]
- Mausbach BT, "Usefulness of the UCSD performance-based skills assessment(UPSA) for predicting residential independence in patients with chronic schizophrenia", J Psychiatr Res, 42, pp.320~327 (2008)[DOI]
- Velligan DI, "The functional significance of symptomatology and cognitive function in schizophrenia", Schizophr Res, 25, pp.21~31 (1997)[DOI]
- Roy-Byrne P, "Evidence for limited validity of the revised global assessment of functioning scale", Psychiatr Serv, 47, pp.864~866 (1996)[DOI]
- 이준영, "총괄기능평가척도(Global Assessment of Functioning Scale)와 사회적, 직업적 기능평가척도(Social and Occupational Functioning Scale)", 대한정신약물학회지, 17(2), pp.122~127 (2006), 대한정신약물학회